Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMMYLTI)

Drug Name

Thyrotropin Alfa Drug Info

Indication

Disease Entry	ICD 11	Status	REF
Thyroid cancer	2D10	Approved	[1]

Therapeutic Class

Diagnostic Agents

Cross-matching ID

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Approved Drug(s)

Investigative Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Thyrotropin receptor (TSHR)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Thyrotropin	DMJ47QC	Hypothyroidism	5A00	Approved	[3]
Recombinant TSH superagonists	DMJQ7XD	Thyroid cancer	2D10	Investigative	[4]
------------------------------------------------------------------------------------

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

References

1	FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 020898.
2	Pharmacological profiles and clinical effects of recombinant human thyrotropin alfa (Thyrogen) Intramuscular Injection 0.9 mg). Nippon Yakurigaku Zasshi. 2009 Jul;134(1):28-34.
3	Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services.
4	URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 255).